openPR Logo
Press release

Alopecia Treatment (Hair Loss) Market Analysis, Research With Cipla, REGAINE, Phyto Corporation, Merck, Ranbaxy, Viviscal Professional, Alès Group, USA, Dr. Reddy's Laboratories, Vitabiotics, Nanogen, Giant Alpecin, Johnson & Johnson, Daiichi Sankyo, Inc

04-23-2019 03:39 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Alopecia Treatment

Alopecia Treatment

This Alopecia Treatment (Hair Loss) market report provides a telescopic view of current market trends, situations, opportunities and status as a source of information that has been established. Moreover, Hair Loss Treatment market report gives customers an idea of the market drivers and restrictions extracted from SWOT analysis and also provides all of the CAGR projections for the 2016, 2017 base year and forecast period 2019-2026. We took up their company profiles in order to truly understand these Alopecia Treatment key players and brands.

Global Alopecia Treatment (Hair Loss) Market is expected to rise from its initial estimated value of USD 8.21 billion in 2018 to an estimated value of USD 12.40 billion by 2026 registering a CAGR of 5.3% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising geriatric population along with high demand for surgical hair transplant and changing lifestyle.

Get Free Sample Analysis of This Market Information: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-alopecia-treatment-hair-loss-market

Alopecia areata is a medical condition which is a type of aloeapa which attacks the hair follicles causes the breakage or fall of hair leading to complete baldness. The patient suffering from alopecia areata, their scalp becomes patchy, diffused and confluent pattern leading the hair fall initially and later spread over the entire scalp termed as alopecia totalis or entire epidermis.

Alopecia areata is an auto immune hair loss on scalp or on body and commonly it shows form of solitary and multiple patches of alopecia.

The global alopecia treatment (hair loss) market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of alopecia treatment (hair loss) market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Alopecia Treatment (Hair Loss) Market

Few of the major market competitors currently working in the alopecia treatment (hair loss) market are Cipla, Viviscal, Dr. Reddy’s Laboratories Ltd., Regaine, Merck & Co., Inc, Ranbaxy Laboratories Ltd, Phyto – Alès Groupe, Kirkland Signature, Vitabiotics, Nanogen, Alpecin – Dr. Kurt Wolff GmbH & Co. KG, Rogaine – Johnson and Johnson, Histogen, Inc., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., HCell Inc., GlaxoSmithKline plc., Perrigo Company PLC. and Daiichi Sankyo, Inc.

Get TOC For Full Analysis Of Report: https://databridgemarketresearch.com/toc/?dbmr=global-alopecia-treatment-hair-loss-market


Market Drivers:

· Rising geriatric population along with high demand for surgical hair transplant will boost the market

· Changing lifestyle along with increase in stress level among working class population can fuel the growth of the market

Market Restraints:

· High cost of alopecia treatment (hair loss) is acting as a major restraint for the market

· Side effects/allergic reactions by treatment also acting as a major market restraint.

Segmentation: Global Alopecia Treatment (Hair Loss) Market

· By Disease Type

o Androgenic Alopecia

o Alopecia Areata

o Ciatricial Alopecia

o Traction Alopecia

o Alopecia Totalis

· By Drug Type

o Minoxidil

o Finasteride

o Cyclosporine

o Others

· By Gender

o Male

o Female

· By Route of Administration

· Oral

o Topical

o Injectable

· By Distribution Channel

o Hospital

o Retail Pharmacies

o Online Pharmacies

· By Geography

o North America

• US
• Canada
• Mexico

o South America

• Brazil
• Argentina
• Rest of South America

o Europe

• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Turkey
• Belgium
• Netherlands
• Switzerland
• Rest of Europe

o Asia-Pacific

• Japan
• China
• South Korea
• India
• Australia
• Singapore
• Malaysia
• Indonesia
• Thailand
• Philippines
• Rest of Asia-Pacific

o Middle East and Africa

• South Africa
• Egypt
• Saudi Arabia
• United Arab Emirates
• Israel
• Rest of Middle East and Africa

Key Developments in the Market:

· In January, 2018, Concert Pharmaceuticals, Inc. announced U.S. FDA granted Fast Track designation for CTP-543, a novel, oral Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe alopecia areata, disease which attacks the hair follicles, leading to hair loss.

· In May 2018, Histogen, Inc (U.S.) announced that received approval to Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to study its lead product in female diffuse hair loss.

· In March 2017, Perrigo Perrigo Company PLC (U.S.) announced the launch of over-the-counter Women’s Rogaine, which helps to regrow hair on top of the scalp.

Want Full Report? Enquire Here: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-alopecia-treatment-hair-loss-market

Reasons to Purchase this Report:

· Current and future of global alopecia treatment (hair loss) market outlook in the developed and emerging markets

· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

· Regions/Countries that are expected to witness the fastest growth rates during the forecast period

· The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

· All segmentation provided above in this report is represented at country level

· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Full Report Description: https://databridgemarketresearch.com/reports/global-alopecia-treatment-hair-loss-market/

About Us

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
https://databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alopecia Treatment (Hair Loss) Market Analysis, Research With Cipla, REGAINE, Phyto Corporation, Merck, Ranbaxy, Viviscal Professional, Alès Group, USA, Dr. Reddy's Laboratories, Vitabiotics, Nanogen, Giant Alpecin, Johnson & Johnson, Daiichi Sankyo, Inc here

News-ID: 1714582 • Views:

More Releases from Data Bridge Market Research

Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 to 2029
Precision gearbox market grow at a CAGR of 9.1% in the forecast period of 2022 t …
Precision gearbox market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to reach at an estimated value of USD 5.9 billion by 2029 and grow at a CAGR of 9.1% in the above-mentioned forecast period. Market Overview This precision gearbox market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031
Neuropathic Pain Market is expected to undergo a CAGR of 9.2% during the forecas …
Data Bridge Market Research analyses that the global neuropathic pain market, which was USD 5.86 billion in 2023, is expected to reach USD 11.86 billion by 2031, and is expected to undergo a CAGR of 9.2% during the forecast period of 2024 to 2031. Market Overview Neuropathic pain is a type of chronic pain caused by damage or dysfunction of the nervous system. It often presents as burning, shooting, or electric shock-kind
Radiology market registering a CAGR of 6.20% during the forecast period of 2022-2029
Radiology market registering a CAGR of 6.20% during the forecast period of 2022- …
Radiology market was valued at USD 26.6 billion in 2021 and is expected to reach USD 43.04 billion by 2029, registering a CAGR of 6.20% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. Market Overview Radiology (also referred as diagnostic imaging) includes multiple tests are included in the process, which
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportunity Analysis
Cervical Retractors Market Size, Share, Trends, Key Drivers, Growth and Opportun …
Global Cervical Retractors Market report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Cervical Retractors market is supposed to grow during the forecast period due to growing demand

All 5 Releases


More Releases for Alopecia

Global Alopecia Market By Disease type: Alopecia Areata, Cicatricial, Traction, …
According to the latest research by SkyQuest Technology, Global Alopecia Market Size was valued at US$ 8.7 billion in 2021, and it is expected to reach a value of US$ 15.10 billion by 2028, at a CAGR of 8.2% over the forecast period (2022 - 2028). The research provides up-to-date Alopecia Market analysis of the current market landscape, latest trends, drivers, and overall market environment. Get full report : https://skyquestt.com/report/alopecia-market The rising
Alopecia Market Research Report Up to 2031
Visiongain has published a new report on Alopecia Market Report to 2031: Forecasts by Disease Type (Androgenic Alopecia, Alopecia Areata, Ciatricial Alopecia, Traction Alopecia, and Alopecia Totalis), By Route of Administration (Oral, Topical, and Injectable), By Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies) PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/alopecia-market/#download_sampe_div COVID-19 Impact on Alopecia Market COVID-19 pandemic has affected more than 200 countries worldwide. Companies have been pressured
Researchers Discover Potential of Alopecia Treatment Market
The Alopecia Treatment Market report gives a weighty source to assess the market and other fundamental technicalities identifying with it. The examination unveils the total assessment and veritable parts of the Alopecia Treatment Market. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report.The trends and expected prospects for
Alopecia Drugs Market Outlook till 2018 to 2022 | By Alopecia Type Alopecia Area …
Market Research Future Published a Prime Research Report on Global Alopecia Drugs Market. The global Alopecia Drugs Market is expected to grow at a CAGR of 6.92% during the Period 2018 to 2022. “Alopecia Drugs Market” Completed Major Study of Alopecia Drugs in Market Research Future. This Report aim is Provide Insights about Factors Affecting the Market Growth. Market Scenario of Global Alopecia Drugs Market: Alopecia is loss of hair due to a
Alopecia Treatment Market - Global Forecast to 2026
Alopecia also called as hair-loss or baldness is a medical condition that refers to loss of hairs from head or any part of the body. The condition can occur in both male and female and at any age. There are five major type of alopecia namely; alopecia areata, androgenic alopecia, ciatricial alopecia, traction alopecia, and alopecia totalis. Alopecia areata is a common autoimmune disorder in which the immune system of
Alopecia Treatment Market - Global Forecast to 2026
Alopecia also called as hair-loss or baldness is a medical condition that refers to loss of hairs from head or any part of the body. The condition can occur in both male and female and at any age. There are five major type of alopecia namely; alopecia areata, androgenic alopecia, ciatricial alopecia, traction alopecia, and alopecia totalis. Alopecia areata is a common autoimmune disorder in which the immune system of